A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

September 7, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

June 30, 2026

Conditions
Trichuriasis
Interventions
DRUG

Albendazole

Albendazole, 5-(prophylthio)-2-benzimidazole carbamate, is a broad-spectrum benzimidazole antihelminthic drug. It is provided as a white to off-white, circular, film-coated tablet with a slightly raised pentagonal projection on either side. This trial will use the 400 mg tablet formulation.

DRUG

Oxfendazole

The active pharmaceutical ingredient is methyl-5 (6)-phenylsulfiyl-2-benzimidazole carbamate, which is a broad-spectrum benzimidazole antihelminthic. Oxfendazole is the sulphoxide metabolite of fenbendazole.

Trial Locations (1)

Unknown

RECRUITING

Policlinico Asociacion Benefica Prisma, Santa Clara de Nanay

All Listed Sponsors
collaborator

Policlinico Asociacion Benefica PRISMA-Laboratorio Satelite IQTLAB

UNKNOWN

collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Iowa

OTHER

collaborator

University of Virginia

OTHER

lead

Asociacion Benefica Prisma

OTHER